The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, ...

As one of the few cancers on the rise, it’s important to know the facts about endometrial cancer—especially if you are a postmenopausal woman. (Women 45 and younger are rarely diagnosed.) ...

Endometrial cancer starts in the tissue that lines your uterus. If the cancer is platinum-resistant, platinum-based chemotherapy drugs will not work well to kill it or stop it from returning after ...

Acrivon Therapeutics said the Food and Drug Administration has granted Breakthrough Device designation for its ACR-368 OncoSignature assay, an immunofluorescence assay for the identification of ...

Part of that spike is due to rising rates of cancers that affect primarily women, including breast cancer and endometrial ...

GSK was able to offset the decline thanks to a better-than-expected performance for its cancer medicines and HIV therapeutics ...

"The lack of a significant link between AmygA and LN metastasis in premenopausal women suggests that menopausal status may ...

Uterine manipulation with an intrauterine device is the surgical method used for early-stage cervical cancer. In this study, ...